tiprankstipranks
TuHURA Biosciences (DE:PL3)
FRANKFURT:PL3
Germany Market
PL3
TuHURA Biosciences
RESEARCH TOOLSreports

TuHURA Biosciences (PL3) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

PL3 Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
TuHURA
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PL3 Stock 12 Month Forecast

Average Price Target

€6.98
▲(181.47% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for TuHURA Biosciences in the last 3 months. The average price target is €6.98 with a high forecast of €7.85 and a low forecast of €6.11. The average price target represents a 181.47% change from the last price of €2.48.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"€8","-1":"-€1","1.25":"€1.25","3.5":"€3.5","5.75":"€5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.85312901,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€7.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.98055912,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.107989229999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.11</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1.25,3.5,5.75,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.92,2.3763945392307693,2.8327890784615386,3.2891836176923075,3.745578156923077,4.201972696153846,4.658367235384615,5.114761774615385,5.571156313846154,6.027550853076923,6.483945392307692,6.940339931538461,7.39673447076923,{"y":7.85312901,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.92,2.3092737784615385,2.698547556923077,3.087821335384615,3.4770951138461537,3.866368892307692,4.25564267076923,4.644916449230768,5.034190227692307,5.423464006153846,5.8127377846153845,6.202011563076923,6.591285341538461,{"y":6.98055912,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.92,2.2421530176923077,2.5643060353846154,2.8864590530769227,3.2086120707692305,3.5307650884615382,3.8529181061538456,4.175071123846154,4.497224141538461,4.819377159230768,5.141530176923077,5.463683194615384,5.785836212307691,{"y":6.107989229999999,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.62,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.79,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.08,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.1,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.444,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.38,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.78,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.92,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€7.85Average Price Target€6.98Lowest Price Target€6.11
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citizens JMP Analyst forecast on DE:PL3
Unknown Analyst
Citizens JMP
Not Ranked
Citizens JMP
€7.85
Buy
216.66%
Upside
Initiated
04/27/26
TuHURA Biosciences initiated with an Outperform at CitizensTuHURA Biosciences initiated with an Outperform at Citizens
Rodman & Renshaw Analyst forecast on DE:PL3
Michael King
Rodman & Renshaw
Rodman & Renshaw
€6.11
Buy
146.29%
Upside
Initiated
04/15/26
TuHURA Biosciences initiated with a Buy at Rodman & RenshawTuHURA Biosciences initiated with a Buy at Rodman & Renshaw
Maxim Group Analyst forecast on DE:PL3
Jason McCarthy
Maxim Group
Maxim Group
€6.98
Buy
181.47%
Upside
Reiterated
03/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on DE:PL3
Robert Burns
H.C. Wainwright
H.C. Wainwright
€8.73
Buy
251.84%
Upside
Reiterated
02/03/26
TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target
Brookline Capital Markets Analyst forecast on DE:PL3
Kumaraguru Raja
Brookline Capital Markets
Brookline Capital Markets
€7.85
Buy
216.66%
Upside
Initiated
06/23/25
TuHURA Biosciences initiated with a Buy at BrooklineTuHURA Biosciences initiated with a Buy at Brookline
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citizens JMP Analyst forecast on DE:PL3
Unknown Analyst
Citizens JMP
Not Ranked
Citizens JMP
€7.85
Buy
216.66%
Upside
Initiated
04/27/26
TuHURA Biosciences initiated with an Outperform at CitizensTuHURA Biosciences initiated with an Outperform at Citizens
Rodman & Renshaw Analyst forecast on DE:PL3
Michael King
Rodman & Renshaw
Rodman & Renshaw
€6.11
Buy
146.29%
Upside
Initiated
04/15/26
TuHURA Biosciences initiated with a Buy at Rodman & RenshawTuHURA Biosciences initiated with a Buy at Rodman & Renshaw
Maxim Group Analyst forecast on DE:PL3
Jason McCarthy
Maxim Group
Maxim Group
€6.98
Buy
181.47%
Upside
Reiterated
03/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
H.C. Wainwright Analyst forecast on DE:PL3
Robert Burns
H.C. Wainwright
H.C. Wainwright
€8.73
Buy
251.84%
Upside
Reiterated
02/03/26
TuHURA Biosciences: Undervalued Orphan-Drug Oncology Pipeline with Multiple Near-Term Catalysts Supports Reiterated Buy and $10 Target
Brookline Capital Markets Analyst forecast on DE:PL3
Kumaraguru Raja
Brookline Capital Markets
Brookline Capital Markets
€7.85
Buy
216.66%
Upside
Initiated
06/23/25
TuHURA Biosciences initiated with a Buy at BrooklineTuHURA Biosciences initiated with a Buy at Brookline
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering TuHURA Biosciences

3 Months
Robert BurnsH.C. Wainwright
Success Rate
4/7 ratings generated profit
57%
Average Return
+73.10%
Copying Robert Burns's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +73.10% per trade.
1 Year
Jason McCarthyMaxim Group
Success Rate
3/8 ratings generated profit
38%
Average Return
+4.49%
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +4.49% per trade.
2 Years
Robert BurnsH.C. Wainwright
Success Rate
3/7 ratings generated profit
43%
Average Return
+66.26%
Copying Robert Burns's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of +66.26% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PL3 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
3
3
4
3
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
4
3
2
In the current month, PL3 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PL3 average Analyst price target in the past 3 months is 6.98.
Each month's total comprises the sum of three months' worth of ratings.

PL3 Financial Forecast

PL3 Earnings Forecast

Next quarter’s earnings estimate for PL3 is -€0.10 with a range of -€0.12 to -€0.09. The previous quarter’s EPS was -€0.12. PL3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year PL3 has its overall industry.
Next quarter’s earnings estimate for PL3 is -€0.10 with a range of -€0.12 to -€0.09. The previous quarter’s EPS was -€0.12. PL3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year PL3 has its overall industry.
No data currently available

PL3 Sales Forecast

Next quarter’s sales forecast for PL3 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. PL3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year PL3 has its overall industry.
Next quarter’s sales forecast for PL3 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. PL3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year PL3 has its overall industry.

PL3 Stock Forecast FAQ

What is DE:PL3’s average 12-month price target, according to analysts?
Based on analyst ratings, TuHURA Biosciences’s 12-month average price target is 6.98.
    What is DE:PL3’s upside potential, based on the analysts’ average price target?
    TuHURA Biosciences has 181.47% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TuHURA Biosciences a Buy, Sell or Hold?
          TuHURA Biosciences has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is TuHURA Biosciences’s share price target?
            The average share price target for TuHURA Biosciences is 6.98. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €7.85 ,and the lowest forecast is €6.11. The average share price target represents 181.47% Increase from the current price of €2.48.
              What do analysts say about TuHURA Biosciences?
              TuHURA Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of TuHURA Biosciences?
                To buy shares of DE:PL3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.